Natasha Karp

Natasha Karp

Principal Scientist - Statistician, AstraZenea
Verified email at astrazeneca.com
Cited by 16631
replicability reproduciblity in-vivo experimental design sex bias
Andre Simpson

Andre Simpson

University of Toronto
Verified email at utoronto.ca
Cited by 15976
Chemistry Environmental Soil NMR In-vivo
Antonio Piras

Antonio Piras

Associate Director, AstraZeneca
Verified email at astrazeneca.com
Cited by 14684
histology image analysis in vivo autophagy in vitro
Ana Maria Camean Fernández

Ana Maria Camean Fernández

Professor in Toxicology. Universidad de Sevilla (Spain)
Verified email at us.es
Cited by 10040
Toxicology Food safety toxicological evaluation in vivo in vitro
Silvia Pichardo

Silvia Pichardo

Catedrática de Toxicología, Universidad de Sevilla
Verified email at us.es
Cited by 5156
Toxicology Food safety toxicological evaluation in vivo in vitro
Malin Hopkins

Malin Hopkins

CEO Redoxis AB
Verified email at redoxis.com
Cited by 4790
inflammation autoimmunitet in vivo
Celina D'Cruz

Celina D'Cruz

Principal Scientist, AstraZeneca
Verified email at astrazeneca.com
Cited by 3204
cancer in vivo molecular biology industry
Alexey V. Sorokin

Alexey V. Sorokin

Group Leader, MD Anderson Cancer Center
Verified email at mdanderson.org
Cited by 3132
Experimental therapeutics Cancer in vivo PDX
Ghislaine Lacroix

Ghislaine Lacroix

INERIS
Verified email at ineris.fr
Cited by 2734
Lung toxicology in vivo in vitro nanoparticles
Marie Beck Iversen

Marie Beck Iversen

Postdoc, Institut for biomedicin, Aarhus universitet
Verified email at biomed.au.dk
Cited by 2304
Biomedicin Immunologi Virologi In vivo
1 - 10